Characterizing PALB2 intragenic duplication breakpoints in a triple-negative breast cancer case using long-read sequencing

Characterizing PALB2 intragenic duplication breakpoints in a triple-negative breast cancer case using long-read sequencing

IntroductionAccurate identification and characterization of Large Genomic Rearrangements (LGR), especially duplications, are crucial for precise diagnosis and risk assessment. In this report, we characterized an intragenic duplication breakpoint of PALB2 to determine its pathogenicity significance.M...

Full description

Bibliographic Details
Main Authors:	Iulian O. Ban, Alice Chabert, Thomas Guignard, Jacques Puechberty, Simon Cabello-Aguilar, Pascal Pujol, Julie A. Vendrell, Jérôme Solassol
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2024-02-01
Series:	Frontiers in Oncology
Subjects:	PALB2 LGR breast cancer long-read sequencing molecular alteration
Online Access:	https://www.frontiersin.org/articles/10.3389/fonc.2024.1355715/full

Similar Items

PALB2 as a factor to predict the prognosis of patients with skull base chordoma
by: Yujia Xiong, et al.
Published: (2022-09-01)

Identification and Characterization of an Exonic Duplication in <i>PALB2</i> in a Man with Synchronous Breast and Prostate Cancer
by: Ahmed Bouras, et al.
Published: (2022-01-01)

A Bioinformatics Toolkit for Next-Generation Sequencing in Clinical Oncology
by: Simon Cabello-Aguilar, et al.
Published: (2023-12-01)

Familial pancreatic cancer with PALB2 and NBN pathogenic variants: a case report
by: Kodai Abe, et al.
Published: (2021-01-01)

Investigation of PALB2 Mutation and Correlation With Immunotherapy Biomarker in Chinese Non-Small Cell Lung Cancer Patients
by: Jiexia Zhang, et al.
Published: (2022-01-01)

Management of PALB2‐associated breast cancer: A literature review and case report
by: Angela Toss, et al.
Published: (2023-08-01)

Evolutionary Origin of Human <i>PALB2</i> Germline Pathogenic Variants
by: Jia Sheng Chian, et al.
Published: (2023-07-01)

Report of a germline double heterozygote in MSH2 and PALB2
by: Konstantinos Agiannitopoulos, et al.
Published: (2020-10-01)

Differential Sensitivity of Germline and Somatic <i>BRCA</i> Variants to PARP Inhibitor in High-Grade Serous Ovarian Cancer
by: Julie A. Vendrell, et al.
Published: (2023-09-01)

Molecular Mechanisms of PALB2 Function and Its Role in Breast Cancer Management
by: Shijie Wu, et al.
Published: (2020-02-01)

KAT2-mediated acetylation switches the mode of PALB2 chromatin association to safeguard genome integrity
by: Marjorie Fournier, et al.
Published: (2022-10-01)

Allelic variants of breast cancer susceptibility genes PALB2 and RECQL in the Latvian population
by: Philip Hilz, et al.
Published: (2019-07-01)

Complete response to talazoparib in patient with pancreatic adenocarcinoma harboring somatic PALB2 mutation: A case report and literature review
by: Andrei Kachmazov, et al.
Published: (2022-09-01)

Recurrent PALB2 mutations and the risk of cancers of bladder or kidney in Polish population
by: Elżbieta Złowocka-Perłowska, et al.
Published: (2021-01-01)

Leptomeningeal carcinomatosis in a patient with PALB2-mutated pancreatic adenocarcinoma: A case report and review of the literature
by: Dylan D. Walker, et al.
Published: (2023-09-01)

Primary Peritoneal Carcinoma in a BRCA1/2-negative, PALB2-positive patient
by: Ryan Kahn, et al.
Published: (2016-08-01)

A rare PALB2 germline variant causing G2/M cell cycle arrest is associated with isolated myelosarcoma in infancy
by: Angelina Beer, et al.
Published: (2021-09-01)

A PALB2-interacting domain in RNF168 couples homologous recombination to DNA break-induced chromatin ubiquitylation
by: Martijn S Luijsterburg, et al.
Published: (2017-02-01)

Loss of the BRCA1-PALB2 interaction accelerates p53-associated tumor development in mice
by: Amar H. Mahdi, et al.
Published: (2022-05-01)

<i>PALB2</i> Variants Extend the Mutational Profile of Hungarian Patients with Breast and Ovarian Cancer
by: Henriett Butz, et al.
Published: (2023-08-01)

Germline <i>PALB2</i> Mutation in High-Risk Chinese Breast and/or Ovarian Cancer Patients
by: Ava Kwong, et al.
Published: (2021-08-01)

PALB2 genetik varyasyonlarının meme kanseri yatkınlığı üzerindeki etkilerinin araştırılması
by: Müge YÜKSEL BİLEN, et al.
Published: (2020-03-01)

Determination of the Optimal Bacterial DNA Extraction Method to Explore the Urinary Microbiota
by: Julie A. Vendrell, et al.
Published: (2022-01-01)

Case Report: Detection of a Novel Germline PALB2 Deletion in a Young Woman With Hereditary Breast Cancer: When the Patient's Phenotype History Doesn't Lie
by: Carmine De Angelis, et al.
Published: (2021-02-01)

Case Report: Co-Existence of BRCA2 and PALB2 Germline Mutations in Familial Prostate Cancer With Solitary Lung Metastasis
by: Tang Tang, et al.
Published: (2020-10-01)

Two Missense Variants Detected in Breast Cancer Probands Preventing BRCA2-PALB2 Protein Interaction
by: Laura Caleca, et al.
Published: (2018-10-01)

Case Report: Effectiveness of Targeted Treatment in a Patient With Pancreatic Cancer Harboring PALB2 Germline Mutation and KRAS Somatic Mutation
by: Wei Wu, et al.
Published: (2022-01-01)

A novel germline mutation of the <i>PALB2</i> gene in a young Yakut breast cancer woman
by: P. A. Gervas, et al.
Published: (2022-09-01)

Frequency of pathogenic germline variants in BRCA1, BRCA2, PALB2, CHEK2 and TP53 in ductal carcinoma in situ diagnosed in women under the age of 50 years
by: Christos Petridis, et al.
Published: (2019-05-01)

Genetic, Surgical and Oncological Approach to Breast Cancer, with BRCA1, BRCA2, CDH1, PALB2, PTEN and TP53 Variants
by: Aslı Subaşıoğlu, et al.
Published: (2023-01-01)

ifCNV: A novel isolation-forest-based package to detect copy-number variations from various targeted NGS datasets
by: Simon Cabello-Aguilar, et al.
Published: (2022-12-01)

Population-based germline testing of BRCA1, BRCA2, and PALB2 in breast cancer patients in the United Kingdom: Evidence to support extended testing, and definition of groups who may not require testing
by: D. Gareth Evans, et al.
Published: (2024-01-01)

Splicing Analysis of 16 <i>PALB2</i> ClinVar Variants by Minigene Assays: Identification of Six Likely Pathogenic Variants
by: Alberto Valenzuela-Palomo, et al.
Published: (2022-09-01)

Prevalence of BRCA1, BRCA2, and PALB2 genomic alterations among 924 Taiwanese breast cancer assays with tumor-only targeted sequencing: extended data analysis from the VGH-TAYLOR study
by: Han-Fang Cheng, et al.
Published: (2023-12-01)

Precision Medicine for <em>BRCA</em>/<em>PALB2</em>-Mutated Pancreatic Cancer and Emerging Strategies to Improve Therapeutic Responses to PARP Inhibition
by: Daniel R. Principe
Published: (2022-02-01)

Converging cultures? A comparative analysis of South Korea and Sweden’s national curricula, 1980–2018
by: Björn Boman, et al.
Published: (2023-01-01)

Clinical Significance of Stem Cell Biomarkers EpCAM, LGR5 and LGR4 mRNA Levels in Lymph Nodes of Colon Cancer Patients
by: Manar AbdelMageed, et al.
Published: (2021-12-01)

Mutations of <i>BRCA1</i>, <i>BRCA2</i>, and <i>PALB2</i> Genes in Breast Tumor Tissue: Relationship with the Effectiveness of Neoadjuvant Chemotherapy and Disease Prognosis
by: Matvey M. Tsyganov, et al.
Published: (2023-07-01)

Transcriptome profiling of LGR5 positive colorectal cancer cells
by: Daniela Hirsch, et al.
Published: (2014-12-01)

LGR6 is a prognostic biomarker for less differentiated tumors in lymph nodes of colon cancer patients
by: Hagar Eltorky, et al.
Published: (2024-04-01)